Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum
JAMA Dermatology · 01.02.2023 · 159 (2) · 226
DOI: 10.1001/jamadermatol.2022.5261 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.02.2023. Verfasst von Juliana Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Texas Southwestern Medical Center, Dallas. Hauptthemen laut MEDLINE: Xeroderma Pigmentosum, Skin Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
This case report describes treatment regimens with topical calcipotriol plus fluorouracil for 2 patients with xeroderma pigmentosum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Texas Southwestern Medical Center, Dallas.
- Department of Dermatology, Massachusetts General Hospital, Boston.
Zitieren
APA
Kim, J., Savory, S. A., Demehri, S., & Gill, J. G. (2023). Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum. JAMA Dermatology, 159(2), 226. https://doi.org/10.1001/jamadermatol.2022.5261
Vancouver
Kim J, Savory SA, Demehri S, Gill JG. Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum. JAMA Dermatology. 2023;159(2):226. doi:10.1001/jamadermatol.2022.5261
BibTeX
@article{Kim2023,
author = {Kim, Juliana and Savory, Stephanie A and Demehri, Shadmehr and Gill, Jennifer G},
title = {Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum},
journal = {JAMA Dermatology},
year = {2023},
volume = {159},
number = {2},
pages = {226},
doi = {10.1001/jamadermatol.2022.5261}
}
EUVIMED